ROCKWELL MEDICAL, INC. (RMTI) Depreciation USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rockwell Medical, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2024.
  • Rockwell Medical, Inc. Depreciation for the quarter ending March 31, 2024 was $400 K, a 100% increase year-over-year.
  • Rockwell Medical, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.4 M, a 100% increase year-over-year.
  • Rockwell Medical, Inc. annual Depreciation for 2023 was $1.2 M, a 100% increase from 2022.
  • Rockwell Medical, Inc. annual Depreciation for 2022 was $600 K, a 10.2% decline from 2021.
  • Rockwell Medical, Inc. annual Depreciation for 2021 was $668 K, a 19.9% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.4 M $400 K +$200 K +100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.2 M $400 K +$100 K +33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.1 M $400 K +$300 K +300% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $800 K $200 K +$100 K +100% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $700 K $200 K +$100 K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $600 K $300 K +$132 K +78.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $468 K $100 K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $468 K $100 K -$100 K -50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $568 K $100 K -$100 K -50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $668 K $168 K +$134 K +394% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $534 K $100 K -$100 K -50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $634 K $200 K -$200 K -50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $834 K $200 K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $834 K $34 K -$154 K -81.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $988 K $200 K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $988 K $400 K +$200 K +100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $788 K $200 K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $788 K $188 K +$38.2 K +25.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $750 K $200 K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $750 K $200 K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $750 K $200 K +$100 K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $650 K $150 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $200 K +$74.2 K +58.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $200 K +$71.2 K +55.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $100 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $126 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $129 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.